Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1997-11-10
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0161-5505
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19N, 23N, 39N
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9379220-Brain Neoplasms,
pubmed-meshheading:9379220-Clinical Trials as Topic,
pubmed-meshheading:9379220-Humans,
pubmed-meshheading:9379220-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9379220-Neoplasms,
pubmed-meshheading:9379220-Radioimmunodetection,
pubmed-meshheading:9379220-Radioimmunotherapy
|
pubmed:year |
1997
|
pubmed:articleTitle |
Emerging radiolabeled therapies hold promise for treatment of cancer.
|
pubmed:publicationType |
News
|